Consistent with this, introduction of IDH1 mutation or exogenous 2-HG in syngeneic mouse glioma models reduces the levels of CTL-attracting and IFN-gamma-inducible chemokines, including CXCL10 [121]. This evidence concerns the gene IDH1 and glioma.